Modus Therapeutics
Latest funding:$3.0M · Post-IPO Equity (June 26, 2025)
Angel investors who backed Modus Therapeutics
12 investors in our database backed Modus Therapeutics.
Chris Jackson
MBA Candidate
Staffan Lindstrand
Partner
Johan Christenson
Partner
Anki Forsberg
Partner
Nikki Matthews
Senior Vice President
Keith Underwood
Senior Vice President
Jason Dodd
Board Member
Laurie Dunk
Controller
George Elish
Executive Vice President
Thomas Wright
CEO
Jonathan Hepple
Partner
Graham Fagg
Partner
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Modus Therapeutics.
Search investors